Annual Results Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'25
Mar'24
EQUITY AND LIABILITIES
No of Months
12
12
Share Capital
4.03
3.28
Share Warrants & Outstandings
Total Reserve
18.63
2.94
Shareholder's Funds
22.66
6.23
Minority Interest
0.00
0.00
Long-Term Borrowings
9.85
7.28
Secured Loans
9.85
7.28
Unsecured Loans
0.00
0.00
Deferred Tax Assets / Liabilities
0.07
-0.01
Other Long Term Liabilities
0.24
0.22
Long Term Trade Payables
0.00
0.00
Long Term Provisions
0.00
0.00
Total Non-Current Liabilities
10.16
7.49
Current Liabilities
Trade Payables
7.27
5.55
Other Current Liabilities
4.01
7.42
Short Term Borrowings
12.31
7.85
Short Term Provisions
0.00
0.00
Total Current Liabilities
23.59
20.81
Total Liabilities
56.41
34.53
ASSETS
Non-Current Assets
0.00
0.00
Gross Block
15.95
12.66
Less: Accumulated Depreciation
2.85
2.41
Less : Impairment of Assets
0.00
0.00
Net Block
13.10
10.25
Lease Adjustment
0.00
0.00
Capital Work in Progress
4.62
0.03
Intangible assets under development
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
Assets in transit
0.00
0.00
Non Current Investments
0.03
0.03
Long Term Loans & Advances
1.11
0.58
Other Non Current Assets
0.53
0.75
Total Non-Current Assets
19.24
11.49
Current Assets Loans & Advances
Current Investments
0.00
0.00
Inventories
13.07
12.40
Sundry Debtors
17.21
8.09
Cash and Bank
4.94
0.36
Other Current Assets
0.09
0.06
Short Term Loans and Advances
1.86
2.14
Total Current Assets
37.17
23.04
Net Current Assets (Including Current Investments)
13.58
2.23
Total Current Assets Excluding Current Investments
37.17
23.04
Miscellaneous Expenses not written off
0.00
0.00
Total Assets
56.41
34.53
Contingent Liabilities
0.00
0.00
Total Debt
0.00
0.00
Book Value per share (adjusted)
56.21
18.96
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 46.46% vs NA in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 9.09% vs NA in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is 72.37% vs NA in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 61.33% vs NA in Mar 2024
Compare Balance Sheet Results of Avience Biomedi.
Figures in Cr
Consolidated - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
4.03
0
4.03
0.00%
Share Warrants & Outstandings
Total Reserve
18.63
0
18.63
0.00%
Shareholder's Funds
22.66
0
22.66
0.00%
Minority Interest
0.00
0
0.00
0.00%
Long-Term Borrowings
9.85
0
9.85
0.00%
Secured Loans
9.85
0
9.85
0.00%
Unsecured Loans
0.00
0
0.00
0.00%
Deferred Tax Assets / Liabilities
0.07
0
0.07
0.00%
Other Long Term Liabilities
0.24
0
0.24
0.00%
Long Term Trade Payables
0.00
0
0.00
0.00%
Long Term Provisions
0.00
0
0.00
0.00%
Total Non-Current Liabilities
10.16
0
10.16
0.00%
Current Liabilities
Trade Payables
7.27
0
7.27
0.00%
Other Current Liabilities
4.01
0
4.01
0.00%
Short Term Borrowings
12.31
0
12.31
0.00%
Short Term Provisions
0.00
0
0.00
0.00%
Total Current Liabilities
23.59
0
23.59
0.00%
Total Liabilities
56.41
0
56.41
0.00%
ASSETS
Non-Current Assets
0.00
0
0.00
0.00%
Gross Block
15.95
0
15.95
0.00%
Less: Accumulated Depreciation
2.85
0
2.85
0.00%
Less : Impairment of Assets
0.00
0
0.00
0.00%
Net Block
13.10
0
13.10
0.00%
Lease Adjustment
0.00
0
0.00
0.00%
Capital Work in Progress
4.62
0
4.62
0.00%
Intangible assets under development
0.00
0
0.00
0.00%
Pre-operative Expenses pending
0.00
0
0.00
0.00%
Assets in transit
0.00
0
0.00
0.00%
Non Current Investments
0.03
0
0.03
0.00%
Long Term Loans & Advances
1.11
0
1.11
0.00%
Other Non Current Assets
0.53
0
0.53
0.00%
Total Non-Current Assets
19.24
0
19.24
0.00%
Current Assets Loans & Advances
Current Investments
0.00
0
0.00
0.00%
Inventories
13.07
0
13.07
0.00%
Sundry Debtors
17.21
0
17.21
0.00%
Cash and Bank
4.94
0
4.94
0.00%
Other Current Assets
0.09
0
0.09
0.00%
Short Term Loans and Advances
1.86
0
1.86
0.00%
Total Current Assets
37.17
0
37.17
0.00%
Net Current Assets (Including Current Investments)
13.58
0
13.58
0.00%
Total Current Assets Excluding Current Investments
37.17
0
37.17
0.00%
Miscellaneous Expenses not written off
0.00
0
0.00
0.00%
Total Assets
56.41
0
56.41
0.00%
Contingent Liabilities
0.00
0
0.00
0.00%
Total Debt
0.00
0
0.00
0.00%
Book Value per share (adjusted)
56.21
0
56.21
0.00%
Annual - Borrowings
Borrowings 22.16 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 46.46% vs NA in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.24 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 9.09% vs NA in Mar 2024
Annual - Fixed Assets
Fixed Assets 17.72 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 72.37% vs NA in Mar 2024
Annual - Investments
Investments 0.03 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Annual - Current Assets
Current Assets 37.17 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 61.33% vs NA in Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
